Psychiatrictimes
Published October 9, 2026
Blinding, Ethics, and Safety Safeguards in Psychedelic Clinical Research | Psychiatric Times
Read the full story at Psychiatrictimes
Psychedelic trials may face blinding failures; concerns around FDA safeguards, active comparators, and filmed sessions.
Surfaced by this Google Alert
- Psychedelics
